Norton Neuroscience Institute Clinical Trials

Norton Neuroscience Institute is at the forefront of neurology and neurosurgery treatment research. As principal investigators on numerous trials, our specialist physicians have access to innovative treatments.

Learn more about participating in a clinical trial at Norton Healthcare.

Active neuroscience clinical trials include:

Aneurysms

Effectiveness and Safety of small aneurysm coiling trial (NANO)

Aneurysms

PULSAR VASCULAR PulseRider® Aneurysm Neck Reconstruction Device HDE Holder Information: Pulsar Vascular, Inc. 130 Knowles Drive, Suite ELos Gatos, CA 95032 USA

Aneurysms

STERLING REGISTRY – A Prospective, Multi-Center, Single Arm, Study to obtain “real world” clinical data and characterize the acute & long term performance of the Micrusframe & Galaxy Coils for the Endovascular treatment of Intracranial […]

Chronic Migraine

Determining the Optimal Treatment Strategy for Patients who have Chronic Migraine with Medication Overuse (MOTS Trial – Medication Overuse Treatment Strategy)

Intracranial Atherosclerotic Disease

The Wingspan Stent System and Gateway PTA Balloon Catheter, a Humanitarian Use Device

Migraine

A Randomized, Multicenter, Double-Blind, Parallel, Sham-Controlled Study Of Non-Invasive Vagus Nerve Stimulation (Nvns) For the Prevention Of Migraines. (Premium II)

Multiple Sclerosis (MS)

A 12-Month, prospective, multicenter, two-cohort, nonrandomized, open-label study in adult patients with Relapsing Multiple Sclerosis (RMS), to investigate changes in immune phenotype biomarkers after treatment with 0.5 mg fingolimod (FTY720) [FLUENT]

Multiple Sclerosis (MS)

TRaditional versus Early Aggressive Therapy for Multiple Sclerosis (TREAT-MS) Trial

Multiple Sclerosis (MS)

Gene Expression and Diagnosis of Autoimmune Disease

Persistent Posttraumatic Headache (PPTH)

A Phase 2, Multicenter, Randomized, Proof-of-Concept, Double-Blind, Placebo-Controlled, Parallel-Group Study Including an Open-Label Period, Evaluating the Efficacy and Safety of 1 Subcutaneous Dose Regimen of Fremanezumab for the Treatment of Posttraumatic Headache (PTH)

Radiation Oncology

Laser Ablation of Abnormal Neurological Tissue using Robotic Neuroblate system (LAANTERN) Prospective Registry

Stroke

PRe-hospital Stroke Scales for ELVO Detection during Initial Care Transport

Stroke

Embotrap eXtraction & Clot EvaLuation & Lesion Evaluation for NeuroThrombectomy – EXCELLENT

Vascular

Cordis Enterprise Vascular Reconstruction Device and Delivery System

Neuro – 1234
Clinical trials

Clinical Trials

Learn more about clinical trials at Norton Healthcare
(502) 629-3501

Deep brain stimulation (DBS) now a treatment for epilepsy

There’s a new treatment option for patients in Louisville with medically-refractory epilepsy. Louisville’s first patient to get deep brain stimulation for epilepsy — a patient treated at Norton Neuroscience Institute — now has an implanted […]

Read Full Story

Patients and caregivers: Learn about the latest advances at the 2019 Neuroscience Expo

The lineup for the 2019 Neuroscience Expo features sessions with neurological experts and others on a range of topics from specific conditions to financial considerations. The Saturday, Sept. 21, 2019, event at the Kentucky International […]

Read Full Story

Neuroscience patients and caregivers: Plan to attend this event for new information

The 2019 Neuroscience Expo – Making Connections will be held Saturday, Sept. 21, 2019, at the Kentucky International Convention Center. Patients and caregivers can get the latest information about treatments, rehabilitation and support for epilepsy; […]

Read Full Story

Disney star Cameron Boyce’s family says a seizure led to his death: What is sudden unexpected death in epilepsy (SUDEP)?

When actor Cameron Boyce, a star of the Disney Channel show “Jessie,” died at age 20, his family said in a statement that his sudden death was due to a seizure during sleep. According to […]

Read Full Story

Feldenkrais class helps patient with MS improve movement

Jackie Stafford was diagnosed with multiple sclerosis (MS) in 1977. Back then, patients with MS were told not to exercise because it was thought that the increase in body temperature during exercise made MS symptoms […]

Read Full Story
Related Stories

Deep brain stimulation (DBS) now a treatment for epilepsy

There’s a new treatment option for patients in Louisville with medically-refractory epilepsy. Louisville’s first patient to get deep brain stimulation for epilepsy — a patient treated at Norton Neuroscience Institute — now has an implanted […]

Read Full Story

Patients and caregivers: Learn about the latest advances at the 2019 Neuroscience Expo

The lineup for the 2019 Neuroscience Expo features sessions with neurological experts and others on a range of topics from specific conditions to financial considerations. The Saturday, Sept. 21, 2019, event at the Kentucky International […]

Read Full Story

Neuroscience patients and caregivers: Plan to attend this event for new information

The 2019 Neuroscience Expo – Making Connections will be held Saturday, Sept. 21, 2019, at the Kentucky International Convention Center. Patients and caregivers can get the latest information about treatments, rehabilitation and support for epilepsy; […]

Read Full Story

Disney star Cameron Boyce’s family says a seizure led to his death: What is sudden unexpected death in epilepsy (SUDEP)?

When actor Cameron Boyce, a star of the Disney Channel show “Jessie,” died at age 20, his family said in a statement that his sudden death was due to a seizure during sleep. According to […]

Read Full Story

Feldenkrais class helps patient with MS improve movement

Jackie Stafford was diagnosed with multiple sclerosis (MS) in 1977. Back then, patients with MS were told not to exercise because it was thought that the increase in body temperature during exercise made MS symptoms […]

Read Full Story

Search our entire site.

Schedule an Appointment

Select an appointment date and time from available spots listed below.